Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
0.9593
Dollar change
-0.0307
Percentage change
-3.10
%
IndexRUT P/E- EPS (ttm)-3.97 Insider Own5.94% Shs Outstand94.67M Perf Week-8.64%
Market Cap91.13M Forward P/E191.86 EPS next Y0.01 Insider Trans-0.18% Shs Float89.35M Perf Month13.23%
Income-331.94M PEG- EPS next Q-0.03 Inst Own49.03% Short Float12.01% Perf Quarter-13.58%
Sales152.07M P/S0.60 EPS this Y-121.82% Inst Trans11.54% Short Ratio9.54 Perf Half Y-63.52%
Book/sh1.46 P/B0.66 EPS next Y104.17% ROA-94.80% Short Interest10.73M Perf Year-84.68%
Cash/sh0.77 P/C1.24 EPS next 5Y25.00% ROE-182.52% 52W Range0.77 - 8.01 Perf YTD-10.35%
Dividend Est.- P/FCF1.86 EPS past 5Y- ROI-186.50% 52W High-88.02% Beta0.97
Dividend TTM- Quick Ratio1.43 Sales past 5Y-9.66% Gross Margin64.04% 52W Low24.58% ATR (14)0.08
Dividend Ex-Date- Current Ratio1.83 EPS Y/Y TTM-272.27% Oper. Margin10.79% RSI (14)48.15 Volatility6.67% 8.28%
Employees53 Debt/Eq0.30 Sales Y/Y TTM-2.66% Profit Margin-218.28% Recom1.00 Target Price3.00
Option/ShortYes / Yes LT Debt/Eq0.29 EPS Q/Q-145.92% Payout0.00% Rel Volume0.83 Prev Close0.99
Sales Surprise-3.39% EPS Surprise- Sales Q/Q-34.49% EarningsMar 11 AMC Avg Volume1.13M Price0.96
SMA20-2.98% SMA506.88% SMA200-60.46% Trades Volume930,379 Change-3.10%
Date Action Analyst Rating Change Price Target Change
Nov-07-22Initiated Lake Street Buy $7
Nov-30-18Downgrade Mizuho Buy → Neutral
Mar-12-24 11:11AM
08:31AM
05:49AM
Mar-11-24 04:26PM
04:01PM
05:07PM Loading…
Mar-04-24 05:07PM
Feb-29-24 04:05PM
Feb-28-24 10:15AM
Feb-26-24 07:57PM
Feb-23-24 11:30AM
05:45AM
Feb-22-24 12:35PM
Feb-19-24 12:39PM
Feb-16-24 12:41PM
11:28AM
05:45AM Loading…
Feb-13-24 05:45AM
Feb-12-24 10:30AM
Feb-09-24 02:51PM
Feb-05-24 03:56PM
10:24AM
10:08AM
Feb-02-24 12:32PM
12:19PM
Jan-29-24 12:30PM
Jan-26-24 09:15AM
Jan-24-24 06:54PM
10:15AM
Jan-22-24 03:42PM
Jan-19-24 09:36AM
Jan-17-24 10:15AM
09:35AM Loading…
09:35AM
Jan-15-24 03:29PM
Jan-10-24 10:45AM
Jan-08-24 12:14PM
Jan-05-24 06:56PM
Jan-04-24 09:46AM
Jan-03-24 08:59AM
Dec-25-23 02:06PM
Nov-14-23 08:00AM
Nov-10-23 01:11PM
Nov-09-23 08:49AM
Nov-08-23 06:46PM
04:30PM
04:01PM
Nov-02-23 12:06PM
Oct-06-23 04:30PM
Sep-22-23 08:38AM
Sep-14-23 01:12PM
Aug-28-23 06:30PM
Aug-25-23 04:05PM
Aug-23-23 08:48AM
Aug-08-23 04:45PM
09:15AM
Aug-06-23 08:05AM
07:14AM
Aug-03-23 04:29PM
04:04PM
Jul-31-23 07:27PM
Jul-27-23 04:01PM
Jul-24-23 08:30AM
Jul-19-23 07:38AM
Jul-07-23 09:16AM
Jun-26-23 07:00AM
Jun-16-23 06:30AM
May-26-23 12:06PM
May-10-23 06:12AM
01:34AM
May-09-23 07:28AM
07:15AM
06:02AM
May-05-23 08:00AM
May-04-23 10:54AM
06:10AM
Apr-27-23 09:00AM
Apr-25-23 01:03PM
06:00AM
Apr-24-23 09:00AM
09:00AM
Apr-17-23 06:43AM
Apr-10-23 09:00AM
Apr-07-23 04:00PM
Mar-29-23 10:13AM
Mar-27-23 09:00AM
Mar-14-23 09:00AM
Mar-10-23 02:37AM
Mar-09-23 12:19PM
Mar-08-23 11:43PM
04:01PM
Mar-06-23 09:00AM
06:00AM
Mar-03-23 09:00AM
Mar-02-23 08:34AM
Mar-01-23 12:41PM
Feb-23-23 07:14AM
Feb-21-23 07:00AM
Feb-20-23 09:00AM
Feb-16-23 08:00AM
Feb-14-23 09:30AM
Feb-13-23 10:31AM
Feb-09-23 06:25AM
Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The firm focuses on portfolio of neurology, inflammation, and pain medications. Its products include INDOCIN, Sympazan, Otrexup, SPRIX, CAMBIA, and Zipsor. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tyree James LDirectorMar 14 '24Sale1.1210,25111,463188,251Mar 15 08:01 PM
Schlessinger SamSVP, General CounselFeb 21 '24Option Exercise0.0017,1510109,384Feb 23 05:32 PM
Patel AjaySVP and CFOFeb 21 '24Option Exercise0.0017,1510141,760Feb 23 05:30 PM
Schwichtenberg PaulSVP, CCOFeb 21 '24Option Exercise0.0017,1510112,430Feb 23 05:31 PM
Schlessinger SamSVP, General CounselFeb 11 '24Option Exercise0.0018,939098,785Feb 13 07:02 PM
Patel AjaySVP and CFOFeb 11 '24Option Exercise0.0047,3480140,991Feb 13 07:00 PM
Schwichtenberg PaulSee RemarksFeb 11 '24Option Exercise0.0047,3480111,661Feb 13 07:01 PM
Schlessinger SamSVP, General CounselOct 01 '23Option Exercise0.0019,404088,442Oct 03 07:27 PM
Peisert Daniel A.President & CEOSep 12 '23Sale2.9731,12192,432324,939Sep 13 08:15 PM
Peisert Daniel A.President & CEOSep 11 '23Sale3.04127,281386,972356,060Sep 13 08:15 PM
Schwichtenberg PaulSVP and CFOSep 11 '23Sale3.07104,980322,59364,313Sep 13 08:16 PM
Patel AjaySVP and CAOSep 11 '23Sale3.0464,313195,79493,643Sep 13 08:17 PM
Schlessinger SamSVP, General CounselSep 11 '23Sale3.0445,236137,44169,038Sep 13 08:18 PM
MCKEE WILLIAMDirectorAug 14 '23Sale3.1422,00069,045238,780Aug 15 06:00 PM
Schlessinger SamSVP, General CounselAug 05 '23Option Exercise0.007,1350117,434Aug 08 07:00 PM
Mason Heather LDirectorMay 19 '23Sale7.3089,286652,011187,650May 22 08:00 PM
Patel AjaySVP and CAOMay 12 '23Option Exercise0.00238,0170314,819May 15 08:58 PM
Schlessinger SamSVP, General CounselMay 12 '23Option Exercise0.00238,0170267,162May 15 08:58 PM
Peisert Daniel A.President and CEOMay 12 '23Option Exercise0.00552,0670797,066May 15 08:57 PM
Schwichtenberg PaulSVP and CFOMay 12 '23Option Exercise0.00238,0170326,156May 15 08:58 PM
Tyree James LDirectorMay 05 '23Sale6.0043,143258,767167,308May 05 09:10 PM